BioCentury | Aug 31, 2017
Product R&D
Cutting through resistance
...wins on efficacy and avoiding resistance. At least three companies -- AmpliPhi Biosciences Corp. , Intralytix Inc....
...CO. (NYSE:DD), Wilmington, Del. Eligo Bioscience S.A.S., Paris, France Intellia Therapeutics Inc. (NASDAQ:NTLA), Cambridge, Mass. Intralytix Inc....
...CO. (NYSE:DD), Wilmington, Del. Eligo Bioscience S.A.S., Paris, France Intellia Therapeutics Inc. (NASDAQ:NTLA), Cambridge, Mass. Intralytix Inc....